搜索
Teva Pharmaceutical Industries Ltd
TEVA添加自选
39.790USD
-0.270-0.67%
交易中 09/22, 10:34（美东）
46.36B总市值
32.31市盈率 TTM
关于 {index_name} Teva Pharmaceutical Industries Ltd 公司
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd 简介
公司代码TEVA
公司名称Teva Pharmaceutical Industries Ltd
上市日期Feb 06, 2087
CEOFrancis (Richard D)
员工数量33892
证券类型Depository Receipt
年结日Feb 06
公司地址124 Dvora Hanevi'a St.
城市TEL AVIV-YAFO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家Israel
邮编6944020
电话97239148213
网址https://www.tevapharm.com/
公司代码TEVA
上市日期Feb 06, 2087
CEOFrancis (Richard D)
Teva Pharmaceutical Industries Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
+11.13%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
+11.35%
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
+12.10%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
常见问题
Teva Pharmaceutical Industries Ltd的前五大股东是谁？
Teva Pharmaceutical Industries Ltd 的前五大股东如下：Mr. Amir Elstein
有多少机构持有Teva Pharmaceutical Industries Ltd(TEVA)的股份？
截至2026Q1，共有1226家机构持有Teva Pharmaceutical Industries Ltd的股份，合计持有的股份价值约为725.07M，占公司总股份的62.27%。与2025Q4相比，机构持股有所增加，增幅为9191465.00。
哪个业务部门对Teva Pharmaceutical Industries Ltd的收入贡献最大？
在2026Q1，Generic products业务部门对Teva Pharmaceutical Industries Ltd的收入贡献最大，创收2.10B，占总收入的50.77%。